drugset / Trial / NCT07029867
Efficacy and Safety of Yishen Daluo Yin Granule for Relapsing-Remitting Multiple Sclerosis
Not yet recruiting
152 enrolled
Ying Gao
Chinese PLA General Hospital · collabFirst Affiliated Hospital of Jinan University · collabThe Second Hospital of Hebei Medical University · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of this study is to evaluate the efficacy and safety of YSDLY granule in patients with RRMS. This will be a multi-center, randomized, double-blind, placebo-controlled study.
Timeline
- Start
- 2026-03-15
- Primary completion
- 2026-10-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Yishen Daluo Yin Granule | Unknown | — | — |